newsfilter
← Latest News
GlobeNewswire·

Genenta to Provide Update on Lead Product Temferon™

MILAN, Italy and NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) -- Luigi Naldini, Ph.D., M.D., co-founder and Executive Scientific Board Chairman of Genenta Science S.p.A. (NASDAQ:GNTA), a clinical-stage immuno-oncology